Shilpa Biologicals Private Limited (SBPL), has entered into a 3 year DefInitive Agreement with Dr. Reddy's Laboratories Limited (DRL) for production-supply of the Sputnik V vaccine from its integrated biologics R&D cum manufacturing center at Dharwad, Karnataka.
The targeted production of the dual vector Sputnik V for the fIrst 12 months is 50 million doses (50 million of Component 1 and 50 million of component 2), from the date of start of commercial production.
- Read more about Shilpa Medicare Limited ties up with Dr. Reddys Laboratories Limited for production of Sputnik V vaccine
- Log in or register to post comments
source https://www.pharmatutor.org/pharma-news/2021/shilpa-medicare-limited-ties-up-with-dr-reddys-laboratories-limited%20for-production-of-sputnik-v-vaccine
No comments:
Post a Comment